Nodexus

San Jose, United States

Nodexus is democratizing access to live single cells for applications including gene editing, drug development, and more.

Dec 2021

Series A

Top Investors

RA Capital ManagementNational Science FoundationS32SkyDeck BerkeleyAstia Angels

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Nodexus's investors?

Nodexus's investors include RA Capital Management, National Science Foundation, S32, SkyDeck Berkeley, Astia Angels.

Where is Nodexus headquartered?

Nodexus is headquartered in San Jose, United States.

What does Nodexus do?

Nodexus is democratizing access to live single cells for applications including gene editing, drug development, and more.

What stage is Nodexus at?

Nodexus is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 16, 2021.

MLA

"Nodexus — Funding & Investors." VCBacked, December 16, 2021, https://www.vcbacked.co/company/nodexus. Accessed July 1, 2026.

APA

VCBacked. (2021). Nodexus — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/nodexus

Wikipedia (cite web)

{{cite web |title=Nodexus — Funding & Investors |url=https://www.vcbacked.co/company/nodexus |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 16, 2021.